Jason M. Rohde
0000-0003-3187-3739
Publication & Citation Trends
Publications
0 total
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer Cells.
Cited by 0
Semantic Scholar
Correction to “An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections” OA
Cited by 1
Semantic Scholar
Discovery and Optimization of 2H-1λ2-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer. OA
Cited by 22
Semantic Scholar
EWS-FLI1–regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth OA
Cited by 24
Semantic Scholar
MOLECULAR CANCER THERAPEUTICS | CANCER BIOLOGYAND TRANSLATIONAL STUDIES EWS-FLI1–regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth
Cited by 0
Semantic Scholar
Ipomoeassin F Binds Sec61α to Inhibit Protein Translocation OA
Cited by 71
Semantic Scholar
Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors OA
Cited by 37
Semantic Scholar
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space OA
Cited by 33
Semantic Scholar
Research Topics
Cancer, Hypoxia, and Metabolism
(13)
Epigenetics and DNA Methylation
(11)
Cancer-related gene regulation
(7)
Microbial Natural Products and Biosynthesis
(6)
Synthetic Organic Chemistry Methods
(5)
Affiliations
Scripps Research Institute
National Institutes of Health
Ironwood Pharmaceuticals (United States)
Institut Charles Sadron
University of California, Irvine